PolarCool AB Stock

Equities

POLAR

SE0012570422

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
0.1255 SEK -4.92% Intraday chart for PolarCool AB +23.04% -52.28%

Financials

Sales 2021 0.75 8.16 1.02 Sales 2022 1.9 20.83 2.6 Capitalization 13.34M 146M 18.23M
Net income 2021 -7M -76.58M -9.57M Net income 2022 -12M -131M -16.4M EV / Sales 2021 63,651,390 x
Net cash position 2021 4.35M 47.6M 5.95M Net cash position 2022 29.35K 321K 40.12K EV / Sales 2022 6,990,729 x
P/E ratio 2021
-6.25 x
P/E ratio 2022
-1.01 x
Employees 3
Yield 2021 *
-
Yield 2022
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.92%
1 week+23.04%
Current month-30.28%
1 month-18.51%
3 months-43.97%
6 months-39.95%
Current year-52.28%
More quotes
1 week
0.10
Extreme 0.102
0.14
1 month
0.05
Extreme 0.05
0.20
Current year
0.05
Extreme 0.05
0.29
1 year
0.05
Extreme 0.05
0.69
3 years
0.05
Extreme 0.05
6.18
5 years
0.05
Extreme 0.05
11.55
10 years
0.05
Extreme 0.05
32.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 42 -
Comptroller/Controller/Auditor 28 -
Sales & Marketing 33 -
Members of the board TitleAgeSince
Chairman - 19-12-31
Director/Board Member 77 17-12-31
Director/Board Member 77 19-12-31
More insiders
Date Price Change Volume
24-04-26 0.1255 -4.92% 39,480
24-04-25 0.132 -1.86% 368,152
24-04-24 0.1345 +21.17% 321,976
24-04-23 0.111 -3.90% 194,046
24-04-22 0.1155 +13.24% 491,464

End-of-day quote NORDIC GROWTH MARKET, April 25, 2024

More quotes
Polarcool AB is a Sweden-based medical device company specializing in sports medicine. The Company focuses on of concussive and sub-concussive brain injuries. It develops a portable brain cooling device called PolarCap System. The PolarCap System consists of a cooling unit and a silicone-based cooling cap alongside neoprene insulation, cooling the head and neck via a circulating coolant during a procedure that takes approximately 45-60 minutes. The idea behind it is the reduction of brain temperature of individuals suffering from a concussion or participating in an activity where repetitive head impact occurs, such as contact and combat sports, in order to prevent or limit long term cognitive impairment. The device undergoes preclinical cohort study for concussion among hockey players and a preclinical study for indication of sub-concussive repetitive head impact among American football players.
More about the company